Ponoi Capital II, LP, 10% Owner, Director at NGM BIOPHARMACEUTICALS INC (NGM), bought 247,640 shares at $4.85 ($1.2M) on 2022-10-26, disclosed to the SEC on 2022-10-27.
Open-market purchase of $1.2M NGM by 10% Owner, Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.75 | 51,046 | $242K | 20.4% |
| 2 | $4.75 | 51,046 | $242K | 20.4% |
| 3 | $4.85 | 72,774 | $353K | 29.6% |
| 4 | $4.85 | 72,774 | $353K | 29.6% |
| Total | $4.81 avg | 247,640 | $1.2M | 100% |
| Filing → |
| NGM | BUY | 2022-05-17 | $842K | — | Filing → |
| RAPT | SELL | 2021-09-29 | $578K | — | Filing → |
| NGM | BUY | 2020-03-25 | $7.1M | — | Filing → |